PP Defence TherapeuticsNews - Page 1

Defence Therapeutics welcomes Dr Svetlana Selivanova to board of directors

Partner News
Defence Therapeutics has announced that Dr Svetlana Selivanova has joined its board of directors, effective immediately.

Defence Therapeutics advances radio-immuno-conjugates with CNRI-H Program approval

Partner News
Defence Therapeutics Inc. has announced a significant milestone in its radio-immuno-conjugates project. The Canadian Nuclear Research Initiative Health (CNRI-H) Program application by Defence Therapeutics has been approved by...

Defence Therapeutics receives no-objection letter from Health Canada for phase I trial of ACCUM-002 (AccuTOX)

Partner News
Defence Therapeutics receives a no-objection letter from Health Canada for a Phase I Trial of ACCUM-002 (AccuTOX) as an anti-cancer molecule in patients with...

Defence Therapeutics’ ARM-X vaccine completely inhibits ovarian cancer growth in treated animals

Partner News
Defence Therapeutics Inc., a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer...

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd

Innovation News Network brings you the latest research and innovation news from the fields of science, environment, energy, critical raw materials, technology, and electric vehicles.

Science

Environment

Energy

Electric Vehicles

Disclaimer: This website is an independent portal and is not responsible for the content of external sites.
Please Note: Phone calls may be recorded for training and monitoring purposes.
© Pan European Networks Ltd